| |
| | United States Patent Application: 0040185445 |
 | | In another embodiment, when the probe is a biological membrane containing a glycolipid, such as a ganglioside or a phosphoinositide (PIP), or a membrane-bound protein such as a G protein-coupled receptor or a ion channel, the common ligand may be a biotinylated lipid molecule, a ganglioside molecule, or a phosphoinositide. |
 | | According to an embodiment, when the common ligands is a biotin-moiety of a probe biologicals in array, or a biotinylated lipid molecule co-existed in probe biological membranes in array, the universal readout unit may be an anti-biotin antibody or a streptavidin. |
 | | The probe biological molecule in the array is preferably an antibody, a recombinant protein, a peptide, an oligosaccharide, or a nucleic acid or peptide aptamer. |
| appft1.uspto.gov /netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=13&f=G&l=50&co1=AND&d=PG01&s1=epsin&OS=epsin&RS=epsin (10700 words) |
|